Latest S-1 registration statements

Azitra, Inc. files an S-1 registration statement for the resale of over 51 million shares by selling stockholders, including those from recent capital raises, while facing NYSE American minimum equity non-compliance.

Actelis Networks, Inc. filed an S-1/A registration statement for the resale of up to 680,422 shares of common stock by selling stockholders, following recent capital raises and Nasdaq compliance efforts.

K2 Capital Acquisition Corporation, a newly formed SPAC, is launching a $100 million IPO to target business combinations in humanoid robotics, physical AI, and small modular nuclear reactors.

ARC Group Acquisition I Corp, a blank check company, filed an S-1/A for its initial public offering of 15 million units, each comprising one Class A ordinary share and one-half of a redeemable warrant, aiming to raise $150 million for a business combination.

GRI Bio, Inc. amended its engagement agreement with H.C. Wainwright & Co., LLC, extending the term for capital raising activities and removing the right of first refusal.

Iron Horse Acquisition II Corp. filed an exhibit-only amendment to its S-1 registration statement, detailing offering expenses, indemnification, and prior unregistered securities sales.

Global Interactive Technologies, Inc. is offering up to 3.8 million shares and warrants in a 'reasonable best efforts' offering to raise capital, facing substantial doubt about its ability to continue as a going concern.

Selling stockholders of Miami International Holdings, Inc. are offering up to 6.75 million common shares, with the company receiving no proceeds from the sale.

Galaxy Digital Inc. reported a significant increase in net income for Q3 2025, driven by gains in digital assets and investments, alongside major expansions in its AI/HPC data center business.

Solidion Technology, an advanced battery company, filed an S-1/A registration statement for the resale of up to 7,076,660 shares of common stock by existing securityholders, with no direct cash proceeds to the company from these sales.

Tempest Therapeutics, a clinical-stage biotechnology company, filed an S-1 registration statement for the resale of 1,172,414 common shares by a selling stockholder, issuable upon warrant exercise.

Banzai International, Inc. filed an S-1 registration statement for the resale of up to 2,076,842 shares of Class A Common Stock, while reporting a significant increase in Q3 2025 revenue driven by recent acquisitions, but also continued substantial operating losses and a 'going concern' warning.

BrooQLy Inc., now operating as Dynamic Aerospace Systems, details its strategic shift to UAV manufacturing and logistics, recent acquisitions, and plans to raise up to $15 million, despite ongoing losses and going concern doubts.

Selling stockholders offer 7 million Class A shares as Legence Corp. reports strong revenue growth and a major acquisition, but also increased net losses and internal control weaknesses.

K2 Capital Acquisition Corporation, a newly formed SPAC, filed an amended S-1 registration statement for a $100 million initial public offering to target businesses in humanoid robotics, physical AI, and small modular nuclear reactors.

Bimergen Energy Corporation files S-1/A for a public offering of 1.32M shares and pre-funded warrants to fund its utility-scale BESS and solar project development, targeting a NYSE listing.

FreeCast, Inc. is preparing for a direct listing on the Nasdaq Global Market, registering 19.78 million Class A common shares for resale, while reporting reduced net losses and significant ad revenue growth, but faces ongoing 'going concern' doubts and a shareholder lawsuit.

Terra Innovatum Global N.V., a micro modular nuclear solutions company, has successfully completed its business combination with GSR III Acquisition Corp. and commenced trading on Nasdaq under the symbol NKLR.

Daedalus Special Acquisition Corp. filed a Rule 462(b) registration statement to offer an additional 2,875,000 units, each comprising one Class A ordinary share and one-fourth of a redeemable warrant.

Focus Universal Inc. files an S-1 registration statement for the resale of up to 10,558,975 shares of common stock by selling stockholders, following a $7 million Series B Preferred Stock private placement.

APPlife Digital Solutions, an aftermarket auto parts e-commerce firm, filed an S-1 registration statement to register shares for resale and to facilitate a $15 million equity purchase agreement with C/M Capital Master Fund LP, amidst ongoing financial challenges and a going concern warning.

Polomar Health Services, Inc. filed an amendment to its S-1 registration statement, detailing offering expenses, indemnification policies, and recent unregistered stock issuances.

Charging Robotics Inc. filed an S-1/A registration statement for the resale of up to 7,928,852 shares of common stock by selling stockholders, contingent on its planned uplisting to the Nasdaq Capital Market.

Guident Corp. filed an S-1/A registration statement for an underwritten public offering of 1,704,545 shares of common stock, aiming for a Nasdaq listing and an estimated price range of $7.80 to $9.80 per share.

First Choice Healthcare Solutions is undergoing a strategic transformation, shifting from orthopedic services to a national network of primary care and wellness clinics, supported by a $12 million public offering.

Andersen Group Inc. files for an initial public offering of 11 million Class A common shares at $14-$16, revealing a complex UP-C structure and significant obligations to existing owners.

Silicon Valley Acquisition Corp., a newly formed SPAC, filed an amended registration statement for its $200 million initial public offering, targeting high-growth sectors like fintech, AI, and energy transition.

GRI Bio, Inc. announces a new public offering of common stock and warrants to raise up to $10 million, alongside positive topline Phase 2a clinical trial results for its lead IPF candidate, GRI-0621, despite ongoing financial challenges and Nasdaq non-compliance.

Ethos Technologies Inc., a digital life insurance platform, has filed an S-1/A registration statement for its initial public offering, highlighting significant revenue growth and recent GAAP profitability.

Klotho Neurosciences, Inc. filed an S-1 registration statement for the resale of up to 35 million shares of common stock by existing selling stockholders, including shares convertible from Series C Preferred Stock.